For now, clinicians should continue to rely on established depression treatments while monitoring ongoing research in this evolving field.
Trial data showed significant triglyceride reductions with Retatrutide treatment, reflecting the interconnection between glucose and fat metabolism
11, 2024, the FDA approved Amneals generic version of AstraZenacas exenatide injection (Byetta)
Charles ED, Neuschwander-Tetri BA, Pablo Frias J et al (2019) Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
Not everyone needs to climb to 15 mg
The glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and now next-generation multi-agonists that include GLP-1 activity, are producing average weight reductions far larger than previously expected from drugs, reshaping clinical practice and how clinicians and patients think about obesity treatment